bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today released three additional case studies -- ...
Picture this: Your doctor orders an imaging test like a chest X-ray in preparation for an upcoming procedure, and the results show a small white spot in the center of your lungs—a pulmonary or lung ...
Workflow Conscious AI ™ facilitates end-to-end improvements in the identification, management, and surveillance of all lung nodule patients - whether identified incidentally or via screening ...
Imidex's Technology is a Front-End Patient Acquisition Tool for Healthcare Providers Targeting Early Lung Cancer Detection, Achieving 83% Sensitivity in Identifying Lung Nodules in Chest X-rays.
LOUISVILLE, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, today announced its financial and operating results for the ...
According to the American Cancer Society, lung cancer is the deadliest cancer in the United States and the second most common type of cancer. A promising new approach could change that: advanced ...
OAK BROOK, Ill. – A new study of more than 10,000 non-smoking adults found that solid lung nodules were present in a considerable portion of study participants. Non-smokers are traditionally thought ...
Noninvasive diagnostic test again leads to detecting Stage 1A lung cancer SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (BIAF) (Nasdaq: BIAF; BIAFW), a biotechnology company advancing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback